Didycz Bozena, Lemańska Dorota, Słuszniak Aleksandra
Klinika Chorób Dzieci Katedry Pediatrii, Uniwersytet Jagielloński Collegium Medium w Krakowie.
Przegl Lek. 2009;66(1-2):11-3.
The phenylketonuria (PKU)/hyperphenylalaninemia (HPA) it is the most frequent inborn genetically conditioned error of metabolism of amino acids. It's occurrence in Polish population was estimated on the level 1:7.000 - 8.500. A. Folling was the first who described the phenylketonuria in 1934. It's diagnosed by neonatal screening, which was initiated in 1963 by prof. R. Guthrie.
since 1985 till 2007 1,172,310 newborns investigated by the neonatal screening proceeding by the Laboratory of Screening and Inborn Errors of Metabolism in Cracow.
in the years 1985-1998 the phenylalanine concentration in drop of blood on the blotting-paper was measured with half-quantitative Guthrie method. However after 1999 the colorimetric quantitative method measurement of phenylalanine concentration in capilar blood was introduced. It 2004 the cut-off value of phenylalanine in drop of blood on filter paper in neonatal screening investigation has was established below 3 mg/dl (till 2003 it was below 4mg/ dl). The blood had been taken from every newborn on filter paper Standard 903 between third and seventh day of the child's life. The verification of recognition in 1985-1988 was applied by Guthrie test, in 1989-2006 by the fluorymetric McCaman and Robins method, and since 2007 by colorimetric method.
in 1985-1998 the group of 137 newborns was distinguished due to the newborn screening (1:4.204), the classic PKU was recognized at 96 (1:5.999), however in next years (after change of method) due to screening 186 (1:4.788) newborns were distinguished, the classic PKU was recognized at 94 (1:5.236) newborn children. The lowering the point of cut-off influenced on frequency recognizing mild HPA, which grew up from 1:25.909 to 1:12.720. In 2001 we verified the recognition at 51 of 93 women (data were have gained over from archive of Outpatient Department), who where identified by the neonatal screening in 1985-1998, and in the face of observed phenylalanine values (<10 mg/dl - mild HPA) did not require dietetic treatment, and they gave up with medical care gradually. With regard on possibility pronouncement the signs of maternal PKU at their offspring, we ask 45 of them to contact with our Outpatient Clinic again, but only 36 with different reasons answered, at 28 of them the phenylalanine concentration was raised: 2-4 mg/dl - in 1 patient; 4-6 mg/ dl - in 6 patients; 6-10 mg/dl - in 11 patients; 10-20 mg/dl - in 12 patients. With this reason at 19 women the low-phenylalanine diet had to be introduce.
苯丙酮尿症(PKU)/高苯丙氨酸血症(HPA)是最常见的先天性氨基酸代谢遗传疾病。据估计,其在波兰人群中的发病率为1:7000 - 8500。1934年,A. 福林首次描述了苯丙酮尿症。1963年,R. 格思里教授发起了新生儿筛查,通过该筛查对其进行诊断。
1985年至2007年,克拉科夫筛查与先天性代谢缺陷实验室对1172310名新生儿进行了新生儿筛查。
1985 - 1998年,采用半定量格思里方法测定滤纸上血滴中的苯丙氨酸浓度。然而,1999年后引入了比色法定量测定毛细血管血中苯丙氨酸浓度的方法。2004年,新生儿筛查中滤纸血滴中苯丙氨酸的截断值设定为低于3mg/dl(2003年之前为低于4mg/dl)。在婴儿出生后的第三天至第七天,从每个新生儿的滤纸上采集血液(标准903)。1985 - 1988年通过格思里试验进行识别验证,1989 - 2006年通过荧光法麦卡曼和罗宾斯方法进行验证,自2007年起采用比色法进行验证。
1985 - 1998年,通过新生儿筛查识别出137名新生儿(1:4204),其中96名被诊断为经典型PKU(1:5999);然而在接下来的几年(方法改变后),通过筛查识别出186名新生儿(1:4788),其中94名新生儿被诊断为经典型PKU(1:5236)。截断值的降低影响了轻度HPA的识别频率,该频率从1:25909增长到1:12720。2001年,我们对1985 - 1998年通过新生儿筛查识别出的93名女性中的51名进行了识别验证(数据从门诊部档案中获取),这些女性的苯丙氨酸值(<10mg/dl - 轻度HPA)不需要饮食治疗,并且她们逐渐放弃了医疗护理。考虑到其后代可能出现母体PKU的迹象,我们要求其中45名再次联系我们的门诊部,但只有36名因不同原因回复,其中28名的苯丙氨酸浓度升高:2 - 4mg/dl - 1例;4 - 6mg/dl - 6例;6 - 10mg/dl - 11例;10 - 20mg/dl - 12例。因此,19名女性不得不采用低苯丙氨酸饮食。